PDT Partners, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
PDT Partners, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$1,151,000
-11.9%
318,700
-13.7%
0.06%
-30.2%
Q4 2016$1,307,000
-24.5%
369,300
-13.8%
0.09%
-14.9%
Q3 2016$1,730,000
-20.5%
428,300
-13.5%
0.10%
-41.3%
Q2 2016$2,175,000–495,400–0.17%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders